Coherus BioSciences, Inc. License Agreements
12 Contracts & Agreements
- Amendment No. 2 to the Exclusive License and Commercialization Agreement, as amended, as of March 13, 2024, by and between Coherus BioSciences, Inc. and Shanghai Junshi... (Filed With SEC on May 9, 2024)
- Exclusive Product License Agreement, dated March 23, 2021, by and between Vaccinex, Inc. and Surface Oncology, Inc (Filed With SEC on March 15, 2024)
- License Agreement, dated June 22, 2022, among Coherus BioSciences, Inc., Bioeq AG and Genentech Inc (Filed With SEC on March 6, 2023)
- License Agreement, dated January 13, 2020, by and between Coherus BioSciences, Inc. and Innovent Biologics (Suzhou) Co., Ltd (Filed With SEC on February 27, 2020)
- License Agreement, dated November 4, 2019, by and between Coherus BioSciences, Inc. and Bioeq IP AG (Filed With SEC on February 27, 2020)
- AMENDED AND RESTATED LICENSE AGREEMENT by and among COHERUS BIOSCIENCES, INC., BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE CORPORATION, AND BAXTER HEALTHCARE SA dated April 10,... (Filed With SEC on May 11, 2015)
- LICENSE AGREEMENT by and among COHERUS BIOSCIENCES, INC., BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE CORPORATION, AND BAXTERHEALTHCARE SA dated August 30, 2013 TABLE OF CONTENTS (Filed With SEC on October 20, 2014)
- LICENSE AGREEMENT by and between BIOGENERICS, INC. and DAIICHI SANKYO COMPANY,LIMITED dated January 23rd, 2012 TABLE OF CONTENTS (Filed With SEC on October 20, 2014)
- CONFIDENTIAL NON-EXCLUSIVE LICENSE AGREEMENT [Cabilly Patents] (Filed With SEC on September 25, 2014)
- FIRST AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on September 25, 2014)
- LICENSE AGREEMENT by and among COHERUS BIOSCIENCES, INC., BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE CORPORATION, AND BAXTERHEALTHCARE SA dated August 30, 2013 TABLE OF CONTENTS (Filed With SEC on September 25, 2014)
- LICENSE AGREEMENT by and between BIOGENERICS, INC. and DAIICHI SANKYO COMPANY,LIMITED dated January 23rd, 2012 TABLE OF CONTENTS (Filed With SEC on September 25, 2014)
